Valuation: Acotec Scientific Holdings Limited

Market Cap 2.11B 2.44B 312M 274M 255M 234M 439M 30.19B 447M 3.05B 1.19B 14.73B 1.17B 1.15B 51.09B P/E 2026 *
15.7x
P/E 2027 * 12.5x
Enterprise Value 2.11B 2.44B 312M 274M 255M 234M 439M 30.19B 447M 3.05B 1.19B 14.73B 1.17B 1.15B 51.09B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.32x
Free-Float
16.21%
Yield 2026 *
-
Yield 2027 * -
1 day-4.53%
1 week-4.18%
Current month-2.38%
1 month-6.59%
3 months-29.73%
6 months-43.11%
Current year-42.22%
1 week 7.6
Extreme 7.6
8.42
1 month 7.54
Extreme 7.54
8.95
Current year 7.54
Extreme 7.54
15.32
1 year 7.54
Extreme 7.54
15.47
3 years 5.26
Extreme 5.26
15.47
5 years 4.21
Extreme 4.21
19.88
10 years 4.21
Extreme 4.21
19.88
Manager TitleAgeSince
Chief Executive Officer 54 29/01/2021
Chief Tech/Sci/R&D Officer 48 29/01/2021
Chief Tech/Sci/R&D Officer 85 29/01/2021
Director TitleAgeSince
Chairman 54 29/01/2021
Director/Board Member 56 03/12/2020
Director/Board Member 79 29/01/2021
Date Insider Type Main position Quantity % Market Cap.
8/6/23 Other

Chief Executive Officer

7,208,000 2.3000%
24/9/21 Other

Chief Executive Officer

342,000 0.1091%
Change 5-day change 1-year change 3-year change Capi.($)
-4.53%-4.18%-35.64%-44.60% 327M
+0.46%-0.76%+35.90%+4.80% 12.45B
-1.76%+8.53%+18.21%+19.39% 6.55B
-0.53%-1.99%+51.79%+21.11% 5.56B
+0.06%+3.09% - - 4.59B
+2.14%+0.83%-27.36%+22.99% 4.38B
-1.76%-0.33%-22.06%-21.97% 4.11B
+28.16%+20.22%+19.56%-48.50% 1.8B
0.00%-7.09%-17.02%+205.07% 1.73B
+0.33%-0.33%+60.10%-3.17% 1.55B
Average +2.26%+1.33%+9.28%+17.23% 4.3B
Weighted average by Cap. +1.00%+2.55%+19.00%+14.60%

Financials

2026 *2027 *
Net sales 728M 843M 107M 94.52M 87.81M 80.76M 151M 10.41B 154M 1.05B 410M 5.08B 403M 395M 17.61B 910M 1.05B 134M 118M 110M 101M 189M 13.01B 193M 1.31B 512M 6.35B 504M 493M 22.02B
Net income 128M 148M 18.9M 16.62M 15.44M 14.2M 26.63M 1.83B 27.11M 185M 72.01M 893M 70.94M 69.41M 3.1B 164M 190M 24.21M 21.29M 19.78M 18.19M 34.12M 2.34B 34.73M 237M 92.27M 1.14B 90.89M 88.93M 3.97B
Net Debt - -
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
653
Date Price Change Volume
23/07/26 HKD 7.800 -4.53% 358,415
22/07/26 HKD 8.170 -0.12% 378,271
21/07/26 HKD 8.180 +4.60% 371,350
20/07/26 HKD 7.820 +2.36% 332,472
17/07/26 HKD 7.640 -7.95% 379,143
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.738CNY
Average target price
15.00CNY
Spread / Average Target
+122.56%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6669 Stock